Against the backdrop of the continued development of the health industry, Beifang Dalu, as a multinational enterprise deeply rooted in the field of life sciences, offers reference value for readers interested in the broader health industry and entrepreneurial cooperation through its industrial layout and compliant operating approach.
Corporate Positioning and Qualification Foundation
Beifang Dalu was founded in 2008 and focuses on high-tech technological innovation research and translational applications in the field of life sciences. The enterprise has a research and development base as a "National High-Tech Enterprise" and "Vice Chairman Unit of the China Health Care Association," and has been rated as a tax credit AAA-level enterprise for many consecutive years. Its brand theme slogan is "Become the leading platform in the era of life economy." In 2015, Beifang Dalu obtained National Direct Selling License No. 72 issued by the Ministry of Commerce, and conducts business on the basis of lawful and standardized operations.
Three Major Industrial Bases and Production Capacity Layout
In terms of production capacity, Beifang Dalu has three major global industrial bases, forming complete supply capacity from research and development to production. Its own base, the Beijing Yanqing Health Industrial Park, is located at the foot of the Badaling Great Wall, with a total area of about 25,200 square meters, an annual production of 1 billion capsules and an annual filling of 50 million oral liquid bottles. The second-phase industrial park under construction has a total building area of 12,200 square meters and is used to continuously expand production capacity. The cooperative base, Jilin Changbai Mountain Ecological Industrial Park, has a total planned area of more than 1,000 hectares and integrates functions such as research and development, production, cultivation and breeding, warehousing and logistics, conferences and exhibitions, and tourism. The research and development base, the Vit Global Supply Base in the United States, covers 30,000 square meters, follows GMP production standards, and produces full-category dosage forms including capsules, tablets, and granules.
A Market Network Covering 27 Countries and Regions Worldwide
In terms of the market, relying on the "Belt and Road" strategy and the "dual circulation" development pattern, Beifang Dalu adopts an "online + offline" and "members + service centers" sales and service model. Its business covers four major regions: North America, Africa, the Middle East, and Southeast Asia, and it has established branches in 27 countries and regions worldwide, forming a business layout covering the entire chain of research and development, production, sales, and service.
Overall, with life sciences as its foundation, compliant operations as its bottom line, and global layout as its direction, Beifang Dalu is steadily advancing platform development in the era of life economy, and also provides partners with an industrial reference worthy of attention.